Evonik shares surge as BASF reportedly sweetens takeover offer to €11B
Evonik Industries AG shares rose 5.2% after BASF SE reportedly increased its takeover offer to €11B ($12.3B), valuing Evonik at €24 per share. The offer includes job guarantees through 2032. Evonik's shares were trading at €20.86, with a market cap of €9.7B. Both companies declined to comment, and a final deal is not certain.
How this was made
The 30-second read
Why it matters
The announcement represents a material M&A event with a multi‑billion euro valuation, likely to drive short‑term trading activity and sector re‑valuation.
Market read
The fresh, high‑premium bid creates immediate trading opportunities for both Evonik and BASF, with broader implications for the European chemicals sector.
What to watch
Potential antitrust review in the EU and the financing structure of the €11 billion offer.
Background
BASF, a leading German chemical producer, is pursuing a takeover of Evonik, a specialty chemicals maker, by offering a premium that lifts Evonik's share price sharply.
Market effects
The chemicals sector may see a re‑rating as consolidation activity intensifies.
European markets could experience broader gains in specialty chemicals stocks.
The deal adds to global M&A momentum, potentially influencing cross‑border investment sentiment.
Counterpoint
If regulatory hurdles or integration risks materialize, the premium could evaporate, pressuring both stocks.
Key entities
- CompanyEvonik Industries AG
Target of the takeover, shares surged 5.2% on the news.
- CompanyBASF SE
Bidder offering >€11 billion, raising the per‑share valuation to €24.
